Summary
The product Superdrol, manufactured by Lemon@arailpharma.me and submitted by Arail Pharmaceuticals, underwent independent testing to verify its composition and potency. The sample, identified by batch number 1, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The test confirmed the presence of Methasterone, with a measured concentration of 10.75 mg.
The testing process began on 5 November 2024, with the sample received on 15 November 2024, and analysis completed on 18 November 2024. While the results confirm the presence of Methasterone, further third-party testing would be necessary to assess product consistency and accuracy across different batches.
Detailed Report
Product Overview
- Product Name: Superdrol
- Manufacturer: Arail Pharmaceuticals
- Active Ingredient: Methasterone
- Batch Number: 1
- Expiration Date: Not provided
- Delivery Method: Oral
Testing Details
- Task Number: #52878
- Testing Ordered: 5 November 2024
- Sample Received: 15 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Arail Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Arail Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 10 mg
- Measured Concentration: 10.75 mg
- Accuracy: 107.50% (7.50% above the label claim)
- Variance: +7.50
Verification Details
- Verification URL: https://janoshik.com/tests/52878_G73KUKHCBCWE
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence of Methasterone in the tested product; however, without a reference dosage claim, it is impossible to assess dosing accuracy. Additionally, as the test was submitted by a specific manufacturer, product consistency across the market remains uncertain. While Janoshik Analytical maintains transparency in testing, independent validation through third-party labs across multiple batches is necessary for a comprehensive evaluation.
Conclusion
The test confirms that Superdrol contains Methasterone (10.75 mg), but without a stated dosage specification, accuracy cannot be determined. Further testing is recommended to ensure quality control across multiple batches. This report is provided to promote harm reduction and support informed decision-making for consumers of anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may have inherent biases, but it still provides valuable insights when cross-checked with independent analysis. Readers should interpret this information critically and responsibly.
